Ticker >

JFL Life Sciences share price

JFL Life Sciences Ltd.

NSE: JFLLIFE SECTOR: Pharmaceuticals & Drugs  21k   5   0

40.15
0 0
NSE: 12 Jun 03:31 PM

Price Summary

Today's High

₹ 40.15

Today's Low

₹ 40.15

52 Week High

₹ 56

52 Week Low

₹ 36.05

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

44.16 Cr.

Enterprise Value

51.28 Cr.

No. of Shares

1.1 Cr.

P/E

13.34

P/B

1.37

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  29.34

CASH

0.06 Cr.

DEBT

7.18 Cr.

Promoter Holding

67.47 %

EPS (TTM)

₹  3.01

Sales Growth

27.51%

ROE

12.9 %

ROCE

15.44%

Profit Growth

0 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1 Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year27.51%
3 Year12.39%
5 YearNA

Profit Growth

1 Year0%
3 Year98.29%
5 YearNA

ROE%

1 Year12.9%
3 Year17.57%
5 Year13.13%

ROCE %

1 Year15.44%
3 Year16.3%
5 Year13.88%

Debt/Equity

0.2225

Price to Cash Flow

-4.87

Interest Cover Ratio

3.61971830985916

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 67.47 0
Sep 2023 67.47 0
Mar 2023 67.47 0
Dec 2022 67.47 0
Sep 2022 67.47 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has significantly decreased its debt by 8.67 Cr.
  • Company has a healthy liquidity position with current ratio of 2.7030223390276.
  • The company has a high promoter holding of 67.47%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 26.985615933314.

 Limitations

  • The company has shown a poor revenue growth of 12.3873704089818% for the Past 3 years.
  • Company has high debtor days of 180.113822087322.
  • Company has negative cash flow from operations of -9.06.

Quarterly Result (All Figures in Cr.)

Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 31.78 30.17 32.77 33.59 42.83
Total Expenditure 30.46 28.31 30.61 28.23 38.9
Operating Profit 1.32 1.86 2.16 5.36 3.93
Other Income 0 0.03 0.09 0.89 1.64
Interest 0.75 1.16 1.23 2.08 1.42
Depreciation 0.15 0.24 0.28 0.37 0.43
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.42 0.5 0.75 3.8 3.72
Tax 0.12 0.14 0.2 0.99 0.91
Net Profit 0.3 0.36 0.54 2.81 2.81
Adjusted EPS (Rs.) 0.55 0.66 0.84 3.5 2.55

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 0.42 0.42 0.5 8.02 11
Total Reserves 4.59 4.95 6.38 3.27 21.27
Borrowings 2.9 1.31 8.18 8.41 1.39
Other N/C liabilities 0.1 0.14 0.19 0.18 0.18
Current liabilities 8.14 17.5 13.76 28.38 15.22
Total Liabilities 16.15 24.33 29.01 48.26 49.06
Assets
Net Block 2.48 5.05 6.5 7.13 6.8
Capital WIP 0.04 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0.03 0.09 0.14 0.8 0.71
Other N/C Assets 0 0.81 1.91 1.03 0.41
Current Assets 13.6 18.37 20.46 39.3 41.14
Total Assets 16.15 24.33 29.01 48.26 49.06
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 0.42 0.5 0.75 3.8 3.72
Adjustment 0.8 1.33 1.41 2.44 1.87
Changes in Assets & Liabilities -4.21 1.47 -7.93 -4.05 -13.65
Tax Paid -0.01 -0.08 -0.09 0.13 -1
Operating Cash Flow -3 3.21 -5.87 2.32 -9.06
Investing Cash Flow -0.61 -2.76 -1.64 -0.71 0.86
Financing Cash Flow 3.61 -0.19 7.25 -1.46 8.07
Net Cash Flow 0 0.27 -0.26 0.15 -0.13

Corporate Actions

Investors Details

PARTICULARS Sep 2022% Dec 2022% Mar 2023% Sep 2023% Mar 2024%
promoters 67.47 67.47 67.47 67.47 67.47
artiben manishkumar patel... 0.20 - 0.20 0.20 0.20
ashokkumar parshottamdas ... 0.27 - 0.27 0.27 0.27
ashwinbhai jivrambhai pat... 0.89 - 0.89 0.89 0.89
dakshaben patel 0.37 - 0.37 0.37 0.37
kirtikumar parshottambhai... 0.12 - 0.12 0.12 0.12
rupesh kirtibhai patel 0.34 - 0.34 0.34 0.34
shobhnaben kirtikumar pat... 0.18 - 0.18 0.18 0.18
smiral ashwinkumar patel 44.33 - 44.33 44.33 44.33
smiral ashwinkumar patel ... 3.98 - 3.98 3.98 3.98
tejal smiral patel 16.58 - 16.58 16.58 16.58
ushaben ashokkumar patel 0.21 - 0.21 0.21 0.21
artiben manishkumar patel... - 0.20 - - -
ashokkumar parshottamdas ... - 0.27 - - -
ashwinbhai jivrambhai pat... - 0.89 - - -
dakshaben patel - 0.37 - - -
kirtikumar parshottambhai... - 0.12 - - -
rupesh kirtibhai patel - 0.34 - - -
shobhnaben kirtikumar pat... - 0.18 - - -
smiral ashwinkumar patel ... - 44.33 - - -
smiral ashwinkumar patel ... - 3.98 - - -
tejal smiral patel - 16.58 - - -
ushaben ashokkumar patel ... - 0.21 - - -
PARTICULARS Sep 2022% Mar 2024%
investors 32.53 32.53
anuj gupta - 1.15
pratik rajendra gandhi - 1.82
econo broking private lim... 2.62 -

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

JFL Life Sciences Stock Price Analysis and Quick Research Report. Is JFL Life Sciences an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into JFL Life Sciences and its performance over the period of time. JFL Life Sciences stock price today is Rs 40.15.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. JFL Life Sciences cash from the operating activity was Rs -9.06 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. JFL Life Sciences has a Debt to Equity ratio of 0.2225 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In JFL Life Sciences , the EPS growth was -27.0913605616919 % which is bad for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, JFL Life Sciences has OPM of 9.17581134718655 % which is a bad sign for profitability.
     
  • ROE: JFL Life Sciences have a average ROE of 12.9017447199265 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of JFL Life Sciences is Rs 40.15. One can use valuation calculators of ticker to know if JFL Life Sciences share price is undervalued or overvalued.
Last Updated on:
Brief about JFL Life Sciences
X